Virginia Commonwealth University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Virginia Commonwealth University sits in the top decile of US sponsors by registered trial count (#63 of 15,742 sponsors by registered trial count).
Virginia Commonwealth University: 558 sponsored US clinical trials, 77 recruiting.
Virginia Commonwealth University sponsors 558 registered US clinical trials on ClinicalTrials.gov, 77 of them currently recruiting, and 380 completed. 35 of these trials are in Phase 3-4 (later-stage) and 145 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 8 trials.
Top-decile sponsor footprint
Virginia Commonwealth University ranks in the top decile of sponsors by registered trial count (#63 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
380 of 462 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
558 total, page 10 of 12
Anakinra to Prevent Adverse Post-infarction Remodeling (2)
NCT01175018
Hyperbaric Oxygen Therapy (HBO2T) for Post-Concussive Symptoms (PSC) After Mild Traumatic Brain Injury (mTBI)
NCT01220713
Pilot Study of the Safety and Efficacy of Carvedilol in Pulmonary Arterial Hypertension
NCT00964678
Effectiveness of Guided Imagery Intervention on Factors Associated With Maternal Stress and Preterm Birth
NCT01436786
Intensity-Modulated External Beam Radiation Therapy in Treating Patients With Prostate Cancer
NCT01117935
Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome
NCT01075425
Ascorbic Acid (Vitamin C) Infusion in Human Sepsis
NCT01434121
Prone Patient Positioning in Reducing Tumor Motion and Improving Breathing Reproduction in Patients With Lung Cancer Undergoing Radiation Therapy
NCT01851161
Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
NCT00963274
Intra-abdominal at Cesarean Section: A Randomized Controlled Trial
NCT01479712
The Causes and Interpretation of Low-level Resistance in Staphylococcus Aureus
NCT01127516
Use of Methacetin Breath Test to Predict Liver Failure in Patients With Cirrhosis
NCT01157845
Correlation Between Vitamin D Status and Bone Mineral Density in Patients With Hemophilia
NCT01090206
Predictors of Rates of Resistant Gram-Negative Bacteria
NCT01075009
Brain Function and Structure in Cocaine Dependence
NCT02080832
Lenalidomide + Azacitidine for Adaptive Immunotherapy -> Auto SCT in Multiple Myeloma
NCT01050790
Antimicrobial Drug Use and Resistant Staphylococcus Aureus
NCT01075451
Study to Explore the Relationships Among Immunity and Stress and the Symptoms of Fatigue, Pain, and Mood Following Guided Imagery in Women With Fibromyalgia
NCT01453647
Characteristics and Outcomes of Intensive Care Unit Patients Admitted With Novel H1N1 Influenza or Seasonal Influenza
NCT01011582
Implantable Cardiac Defibrillators for the Prevention of Sudden Death in Patients With Cardiac Sarcoidosis
NCT01013311
Probiotic Lactobacillus GG (LGG) in Patients With Minimal Hepatic Encephalopathy
NCT00992290
Pilot Study to Determine the Effectiveness of Antimicrobial Healthcare Worker's (HCW) Hands and Clothing
NCT00971373
Brain Injury Inpatient Educational Intervention for Families and Caregivers
NCT01062243
Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition
NCT00571415
Evaluating the Acute Effects of Electronic Nicotine Delivery Devices Marketed to Smokers.
NCT00932295
Effects of Pioglitazone on Insulin and Glucose Metabolism in Women With Polycystic Ovary Syndrome (PCOS)
NCT00868140
Desensitization of Human Mast Cells: Mechanisms and Potential Utility for Preventing Anaphylaxis
NCT00868842
Image-Guided Adaptive Radiotherapy for in Detecting Tumors During Treatment in Patients With Head and Neck Cancer
NCT01843673
Reducing HIV: Safer Sex Skill Building in Pregnant Drug Abusing Women
NCT00619320
Anakinra to Prevent Post-infarction Remodeling
NCT00789724
An fMRI Study of SYN115 in Cocaine Dependent Subjects
NCT00783276
An Intervention Targeting Fruit and Vegetable Intake Among Rural Youth
NCT01412697
Radiofrequency Ablation vs Laser Ablation of the Incompetent Greater Saphenous Vein
NCT02236338
Radiofrequency Ablation vs. Laser Ablation of the Incompetent Small Saphenous Vein
NCT02248740
A Multicenter Data Registry for Outcomes From Surgical Treatment of Atrial Arrhythmias
NCT00747838
Organizational Factors Influencing Practice Improvement in Community Based Care
NCT00746577
Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT
NCT00709592
Pharmacogenetics of Metformin Action in PCOS
NCT00703508
5-Azacytidine Prior to Allogeneic Stem Cell Transplant in High Risk Myelodysplastic Syndrome
NCT00721214
Effects of Flutamide on Insulin and Glucose Metabolism in Women With Polycystic Ovary Syndrome
NCT00729560
Clinical Neurobiology of Serotonin and Addiction
NCT00732901
NOURISH: Nourishing Our Understanding of Role Modeling to Improve Support and Health
NCT00628030
Caffeine and Cocaine
NCT00733993
Conservation of Red Cell Mass , Oxygen Supply and Demand in Cardiac Surgery
NCT00660608
Relationship Between Alcohol Use Disorders and Cortisol Levels in Patients With Sepsis
NCT00615862
Nerve Growth Factor in Chronic Pancreatitis
NCT01255917
Implantation of Markers for the Radiotherapy of Lung Cancer Patients
NCT00856427
Pilot Study:Role of Dietary Fiber in PCOS Anovulation
NCT00703092
Exercise and Manual Therapy for Shoulder Subacromial Impingement Syndrome
NCT00632996
Energy Costs of Spasticity in Spinal Cord Injury: A Pilot Investigation
NCT00572845
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 80 |
| Phase 2 | 65 |
| Phase 3 | 13 |
| Phase 4 | 22 |
Therapeutic Areas
What is open in the Virginia Commonwealth University pipeline
77 recruiting of 558 indexed (14% open); 380 completed (68%).
Phase mix: 35 late (III/IV) vs 145 early (I/II) (early-phase heavy).
Top condition: Obesity (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Virginia Commonwealth University: open-pipeline peers nationwide
Peers matched on 558 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Virginia Commonwealth University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 558 trials (± recruiting share)
- Amgen · 558 trials · 10% recruiting
- Merck Sharp & Dohme · 558 trials · 22% recruiting
- University of Maryland, Baltimore · 560 trials · 18% recruiting
- Ohio State University · 552 trials · 21% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Lindenwood University · 14% recruiting · 29 trials
- BeiGene · 14% recruiting · 65 trials
- Reproductive Medicine Associates of New Jersey · 14% recruiting · 51 trials
- University of Cincinnati · 14% recruiting · 245 trials
Related
What to do with this Virginia Commonwealth University page
558 registered trials is a research-attention snapshot, not an endorsement of Virginia Commonwealth University or any single study.
- 77 of Virginia Commonwealth University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Virginia Commonwealth University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Virginia Commonwealth University pipeline card: 558 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.